Decreased CSF Aβ42 correlates with brain atrophy in cognitively normal elderly

Por Fagan, Anne M., Head, Denise, Shah, Aarti R., Marcus, Daniel, Mintun, Mark, Morris, John C., Holtzman, David M.
Publicado em 2009

Neutrophil elastase and neurovascular injury following focal stroke and reperfusion

Por Stowe, Ann M., Adair-Kirk, Tracy L., Gonzales, Ernesto R., Perez, Ronald S., Shah, Aarti R., Park, Tae S., Gidday, Jeffrey M.
Publicado em 2009

CSF Proteins Predict Longitudinal Hippocampal Degeneration in Early Stage Dementia of the Alzheimer Type

Por Wang, Lei, Fagan, Anne M., Shah, Aarti R., Beg, Mirza Faisal, Csernansky, John G., Morris, John C., Holtzman, David M.
Publicado em 2012

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease

Por Fagan, Anne M, Mintun, Mark A, Shah, Aarti R, Aldea, Patricia, Roe, Catherine M, Mach, Robert H, Marcus, Daniel, Morris, John C, Holtzman, David M
Publicado em 2009

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms

Por Wahrle, Suzanne E, Shah, Aarti R, Fagan, Anne M, Smemo, Scott, Kauwe, John SK, Grupe, Andrew, Hinrichs, Anthony, Mayo, Kevin, Jiang, Hong, Thal, Leon J, Goate, Alison M, Holtzman, David M
Publicado em 2007

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

Por Perrin, Richard J., Craig-Schapiro, Rebecca, Malone, James P., Shah, Aarti R., Gilmore, Petra, Davis, Alan E., Roe, Catherine M., Peskind, Elaine R., Li, Ge, Galasko, Douglas R., Clark, Christopher M., Quinn, Joseph F., Kaye, Jeffrey A., Morris, John C., Holtzman, David M., Townsend, R. Reid, Fagan, Anne M.
Publicado em 2011

Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age

Por Sutphen, Courtney L., Jasielec, Mateusz S., Shah, Aarti R., Macy, Elizabeth M., Xiong, Chengjie, Vlassenko, Andrei G., Benzinger, Tammie L. S., Stoops, Erik E. J., Vanderstichele, Hugo M. J., Brix, Britta, Darby, Heather D., Vandijck, Manu L. J., Ladenson, Jack H., Morris, John C., Holtzman, David M., Fagan, Anne M.
Publicado no JAMA Neurol (2015)

SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease

Por Cruchaga, Carlos, Kauwe, John S. K., Mayo, Kevin, Spiegel, Noah, Bertelsen, Sarah, Nowotny, Petra, Shah, Aarti R., Abraham, Richard, Hollingworth, Paul, Harold, Denise, Owen, Michael M., Williams, Julie, Lovestone, Simon, Peskind, Elaine R., Li, Ge, Leverenz, James B., Galasko, Douglas, Morris, John C., Fagan, Anne M., Holtzman, David M., Goate, Alison M.
Publicado em 2010

BRAIN ABNORMALITIES IN YOUNG ADULTS AT GENETIC RISK FOR AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE: A CROSS-SECTIONAL STUDY

Por Reiman, Eric M., Quiroz, Yakeel T., Fleisher, Adam S., Chen, Kewei, Velez-Pardo, Carlos, Jimenez-Del-Rio, Marlene, Fagan, Anne M., Shah, Aarti R., Alvarez, Sergio, Arbelaez, Andrés, Giraldo, Margarita, Acosta-Baena, Natalia, Sperling, Reisa A., Dickerson, Brad, Stern, Chantal E., Tirado, Victoria, Munoz, Claudia, Reiman, Rebecca A., Huentelman, Matthew J., Alexander, Gene E., Langbaum, Jessica B.S., Kosik, Kenneth S., Tariot, Pierre N., Lopera, Francisco
Publicado em 2012